PIB TrackerNCB makes India's first Captagon seizure
Operation RAGEPILL intercepts the Middle East's "jihadi drug" moving in transit through India, the country's first-ever interdiction of the amphetamine-type stimulant.
What happened
- The Narcotics Control Bureau (NCB), India's apex anti-narcotics agency under the Ministry of Home Affairs, ran an operation codenamed Operation RAGEPILL that broke open an international synthetic-drug syndicate trafficking Captagon.
- The agency seized about 227.7 kg of Captagon tablets and powder and arrested one overstaying Syrian national. The Union Home Minister put the illicit market value at roughly ₹182 crore in Gulf and Middle East markets.
- The lead came from a Foreign Drug Law Enforcement Agency that warned India was being used as a transit route for Captagon. Acting on it, a house in Neb Sarai, New Delhi was searched on 11 May 2026, recovering about 31.5 kg of Captagon tablets concealed inside a commercial chapati-cutting machine that was meant for export to Jeddah, Saudi Arabia.
- Questioning led to a further recovery of about 196.2 kg of Captagon powder from a container at the Container Facilitation Station (CFS), Mundra, Gujarat on 14 May 2026. The container had been imported from Syria with sheep wool as the declared consignment.
- The arrested man had entered India on a tourist visa on 15 November 2024; his visa expired on 12 January 2025 and he was illegally overstaying when intercepted.
- Officials described this as India's first-ever Captagon seizure, exposing the misuse of Indian territory and ports as a relay point between source regions and consuming markets abroad.
- NCB has opened a wider probe into the procurement source, hawala linkages, logistics facilitators and the intended international receivers, and has urged the public to report drug information through the MANAS Helpline (toll-free 1933).
Background & context
Captagon is the brand name under which the synthetic stimulant fenetylline was first marketed in the 1960s as a milder treatment for attention disorders, narcolepsy and depression. Fenetylline is a prodrug: once swallowed, the body metabolises it into amphetamine and theophylline, producing a powerful stimulant effect — alertness, suppressed appetite, reduced fear and fatigue. Because of its high abuse potential, fenetylline was placed under international control by the late 1980s. The legitimate pharmaceutical product has long since disappeared; what circulates today is counterfeit "Captagon", illicitly manufactured tablets typically stamped with a twin-crescent logo and containing amphetamine cut with caffeine and other fillers. The name survived even though the original molecule rarely does.
Over the past decade Captagon has become the defining illicit drug of the Levant and the Arabian Peninsula. It earned the labels "the jihadi drug" and "chemical courage" after reports that fighters in West Asian conflict zones used it to stay awake and fearless for long stretches, and it later became a mass-market recreational and party drug across the Gulf, where its trade is estimated to run into billions of dollars. Production has been concentrated in the conflict-hit Levant, and consumption is heaviest in wealthy Gulf states such as Saudi Arabia. The India angle in this case — a consignment routed from Syria and onward-bound for Jeddah — fits that established source-to-market geography exactly, with India inserted only as a transit leg, not as a producer or a consumer market.
The seizing agency, the Narcotics Control Bureau, was constituted in 1986 as the central nodal drug-law-enforcement and intelligence agency, created under the Narcotics Drugs and Psychotropic Substances (NDPS) Act, 1985 and functioning under the Ministry of Home Affairs (it was earlier under the Department of Revenue, Ministry of Finance). The drug itself is controlled in India because both of its named active ingredients — fenetylline and amphetamine — are "psychotropic substances" listed under the NDPS Act, the statute that governs the manufacture, possession, sale, transport and trafficking of narcotic drugs and psychotropic substances in India.
For Prelims
- Operation: Operation RAGEPILL — the NCB codename under which the syndicate was busted and the Captagon seized.
- Agency: Narcotics Control Bureau (NCB) — India's apex / nodal drug-law-enforcement and intelligence coordination agency, set up in 1986, now under the Ministry of Home Affairs (not Finance/Revenue today).
- Governing law: Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 — the legal basis for NCB and for treating Captagon's ingredients as controlled substances.
- What Captagon is: a synthetic amphetamine-type stimulant; the brand name originally carried the drug fenetylline, which metabolises into amphetamine and theophylline. The case body names its active ingredients as fenetylline + amphetamine, classed as psychotropic substances under the NDPS Act.
- Quantity & value: ~227.7 kg of tablets/powder; illicit value ~₹182 crore in Gulf/Middle East markets. Split: ~31.5 kg (tablets, Delhi) + ~196.2 kg (powder, Mundra).
- Geography of the case: seizures at Neb Sarai, New Delhi (11 May 2026) and CFS Mundra, Gujarat (14 May 2026); container imported from Syria (declared as sheep wool); tablets bound for Jeddah, Saudi Arabia, concealed in a chapati-cutting machine. India figured only as a transit hub.
- The arrest: one Syrian national, on a tourist visa from 15 Nov 2024, overstaying since the visa expired on 12 Jan 2025.
- Reporting channel: MANAS Helpline 1933 — NCB's national toll-free anti-narcotics helpline/portal for tips and de-addiction support.
- The lead-in case: this followed a recent NCB interdiction in Mumbai of 349 kg of cocaine in a container from Ecuador — a separate route and substance.
What it is NOT: Captagon is not a plant-based / natural drug like heroin (opium poppy), cocaine (coca) or cannabis (hemp) — it is a wholly synthetic stimulant, which is why it falls under the "psychotropic substance" head and not the "narcotic drug" head in everyday usage. It is not an opioid or a depressant; it is a stimulant. India here is not the source or the destination market — only the transit point. And the NCB is not a regulatory licensing body for medicines (that is CDSCO/DCGI); the NCB is the enforcement and intelligence-coordination agency for illicit drugs.
The wider drug-control architecture
For "how many of these" and "match the pairs" questions, it helps to place this case inside the full Indian anti-narcotics set-up. The NDPS Act, 1985 is the parent statute; it created the legal scaffolding and led to the formation of the NCB in 1986 as the central coordinating agency. Alongside NCB, drug enforcement is shared by other agencies that the syllabus expects you to recognise as actors: the Directorate of Revenue Intelligence (DRI) and Customs (for cross-border and container/port seizures, relevant here at Mundra), the state police, and the Border Security Force / Sashastra Seema Bal / Coast Guard on the land and maritime frontiers. Policy is steered through the Narco-Coordination (NCORD) mechanism, which links central and state agencies, and the government runs the Nasha Mukt Bharat Abhiyaan (NMBA) on the demand-reduction / de-addiction side. The MANAS portal and helpline (1933), launched to give citizens a single national point to report drug activity and seek help, is the public-facing front of this architecture.
India sits on two well-known illicit-opium belts that frame most narcotics questions: the Golden Crescent (Afghanistan–Iran–Pakistan) to the north-west and the Golden Triangle (Myanmar–Laos–Thailand) to the east. Captagon adds a third vector — a synthetic, West-Asian drug flow that does not fit either traditional belt, which is precisely why this seizure matters: it signals that India's coastlines, container ports and courier routes are being tested as relay points for synthetic drugs manufactured elsewhere, not just as a market for the older plant-based opiates.
Why it matters
The significance is less the tonnage and more the precedent. A "first-ever" seizure of a drug means a new commodity has entered the country's trafficking map, and the modus operandi here — concealment inside an industrial machine for export, and bulk powder hidden in a wool consignment shipped through a major container port — shows traffickers treating Indian export logistics as a laundering layer to "clean" the origin of West-Asian-bound drugs. That is a national-security and border-management problem as much as a public-health one: it implicates port and container screening, visa-overstay monitoring (the accused had overstayed by over a year), hawala and trade-based money-laundering channels, and intelligence-sharing with foreign drug-enforcement agencies, since the original lead came from abroad. The case also demonstrates the value of international cooperation and of agencies working a single thread — from a tip-off, to a Delhi house, to a Gujarat port container — to map an entire syndicate rather than make one isolated catch.